Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 212 Lung Neoplasms 74 Neoplasms 24 Adenocarcinoma of Lung 16 Neoplasm Metastasis 15 Mesothelioma, Malignant 15 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Mesothelioma 12 Carcinoma 11 Head and Neck Neoplasms 10 Breast Neoplasms 8 Adenocarcinoma, Bronchiolo-Alveolar 7 Small Cell Lung Carcinoma 6 Ovarian Neoplasms 6 Recurrence 5 Pancreatic Neoplasms 4 Colorectal Neoplasms 4 Adenocarcinoma 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Prostatic Neoplasms 3 Lung Diseases 3 Laryngeal Diseases 3 Carcinoma, Small Cell 3 Brain Neoplasms 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Thoracic Neoplasms 2 Solitary Fibrous Tumor, Pleural 2

Interventions

Doxorubicin 33 Ifosfamide 23 Gemcitabine 19 pazopanib 18 Cyclophosphamide 16 Radiotherapy 15 pembrolizumab 13 Filgrastim 12 Docetaxel 12 Bevacizumab 10 Vincristine 9 Sirolimus 9 Irinotecan 9 Etoposide 9 olaratumab 7 eribulin 7 Sorafenib 7 Radiation 7 temsirolimus 6 Temozolomide 6 Mesna 6 Magnetic Resonance Spectroscopy 6 Cisplatin 6 tazemetostat 5 cixutumumab 5 Trabectedin 5 Radiosurgery 5 Nivolumab 5 Ipilimumab 5 Granulocyte Colony-Stimulating Factor 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Sarcoma × Pemetrexed × Clear all

NCT00860015 2020-08-25

Alimta Plus Gemcitabine for Advanced Sarcoma

Columbia University

Phase 2 Completed

12 enrolled 4 charts

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡